Bioactive Small Molecules|Pharmaceutical Intermediates|Heterocyclic Building Blocks | Sun-shinechem

We Can Provide

RECOMMENDED PRODUCTSMore>>

18435

Ritlecitinib ( PF-06651600 )

Ritlecitinib ( PF-06651600 ) is a potent and selective JAK3 inhibitor. PF-06651600, a

18382

eCF506

eCF506 targets a molecule called Src tyrosine kinase that is required for breast canc

2073102

BMS-1166

BMS-1166is a potent PD-1/PD-L1 interaction inhibitor with an IC50 of 1.4 nM, antagoni

208192

BCH001

BCH001,a specific PAPD5 inhibitor, restored telomerase activity and telomere length i

121417

BMS-777607

BMS-777607 is an inhibitor of MET tyrosine kinase with potential antineoplastic activ

16122847

WWL70

WWL70 is selective ABHD6 inhibitor, and it has shown anti-inflammatory and neuroprote

2017878

Elenbecestat ( E2609 )

Elenbecestat (E2609) is a potent, orally bioavailable and CNS-penetrant BACE-1 inhibi

2073106

Lerociclib HCl (G1T38 HCl)

Lerociclib HCl (G1T38)is a novel, selective,differentiated oral CDK4/6 inhibitor with

Sun-shine chemical offers a full range of services in
custom organic synthesis

NEW PRODUCTSMore>>

18435 | Ritlecitinib ( PF-06651600 )

184351792180-81-4

Ritlecitinib ( PF-06651600 )

208191 | OATD-01

2081912088453-21-6

OATD-01

2091501 | AB-680

20915012105904-82-1

AB-680

20911 | IACS-9439

209112231259-57-5

IACS-9439

20103001 | ASN007

201030012055597-12-9

ASN007

2073103 | Remibrutinib ( LOU064 )

20731031787294-07-8

Remibrutinib ( LOU064 )

20103002 | Senaparib

201030021401682-78-7

Senaparib

62502 | TG02 ( SB1317 )

62502937270-47-8

TG02 ( SB1317 )